Can-Fite BioPharma Ltd. Sale of Stock, Consideration Received on Transaction
Can-Fite BioPharma Ltd. (CANF) had Sale of Stock, Consideration Received on Transaction of $3.00 million as of 2025-04-14, per its 6-K filed 2025-08-28.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2025-08-28
- 2025-04-14: Sale of Stock, Consideration Received on Transaction $3.00M.
| Period end | Sale of Stock, Consideration Received on Transaction |
|---|---|
| 2025-04-14 | $3.00M 6-K · filed 2025-08-28 |